Abstract
Background and study aim
Flexible sigmoidoscopy (FS) is a feasible examination technique and a suitable tool for population-based screening, but very little is known about determinants of endoscopic screening participation. The aim of this study was to determine the acceptance rate and the factors influencing the decision of participating in a screening program for patients in an outpatient clinic.
Materials and methods
In this prospective study, a colorectal cancer screening by FS was offered to 631 patients older than 40 years. Three strategies were available, (1) to have the endoscopy on the same day, (2) to make an appointment for another day, or (3) to take time to think about if they wanted the procedure. The reasons for refusal of the FS were documented.
Results
419 of the 631 (66.4%) patients had no interest to take part in the screening program during their outpatient visit. Two hundred twelve (33.6%) patients were primarily interested on FS, but only 110 of them were finally examined. In total, 102 patients did not make an appointment for FS or did not appear for the endoscopy. The participation rate was therefore 17.4% (110/631) of all patients. Of the patients who agreed to receive an on-site examination, 78.3% were examined compared to 18.8% of patients who fixed the appointment for another day or after taking time to reflect upon the FS procedure. More male than female patients accepted the FS screening. Recommended colonoscopy was finally performed in 76%. Thirty-three polyps were found during the screening program of which 18 were larger than 0.5 cm. No CRC was detected. All patients agreed to repeat the FS every 5 years.
Conclusions
This study demonstrates that a screening examination will be most likely performed if it is done as an on-site examination. In contrast, the participation rate is low if the patient has to make an appointment by himself. Acceptance of FS screening is also dependent on the patient’s gender and family history of cancer. Additional strategies are needed to further improve participation.
Similar content being viewed by others
References
Krebs in Deutschland (2002) Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland. 3. erweiterte, aktualisierte Ausgabe, Saaarbrücken
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365–1371
Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472–1477
Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91:434–437
Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD (2002) Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50:840–844
Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603–1607
Atkin WS, Northover JM (2003) Protagonist: population based endoscopic screening for colorectal cancer. Gut 52:321–322
Gnauck R (1995) Screening for colon cancer in Germany. Tumori 81:30–37
Sharma VK, Corder FA, Raufman JP, Sharma P, Fennerty MB, Howden CW (2000) Survey of internal medicine residents’ use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance. Am J Gastroenterol 95:2068–2073
Young GP, St John DJ, Winawer SJ, Rozen P (2002) Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97:2499–2507
Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653–657
Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84:1572–1575
Müller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 123:904–910
Armbrecht U, Manus B, Bragelmann R, Stockbrugger RW, Stolte M (1994) Acceptance and outcome of endoscopic screening for colonic neoplasia in patients undergoing clinical rehabilitation for gastrointestinal and metabolic diseases. Z Gastroenterol 32:3–7
Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover JM (1998) Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42:560–565
Cooper GS, Fortinsky RH, Hapke R, Landefeld CS (1998) Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer 82:1476–1481
Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM (1998) Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 317:182–185
Levin TR, Conell C, Shapiro JA, Chazan SG, Nadel MR, Selby JV (2002) Complications of screening flexible sigmoidoscopy. Gastroenterology 123:1786–1792
Vernon SW (1995) Adherence to colorectal cancer screening. A brief overview. Ann NY Acad Sci 768:292–295
Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89:1406–1422
Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594–642
Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA (1997) American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 47:154–160
Schmiegel W, Pox C, Adler G, Fleig W, Folsch UR, Fruhmorgen P, Graeven U, Hohenberger W, Holstege A, Kuhlbacher T, Porschen R, Propping P, Riemann JF, Sauer R, Sauerbruch T, Schmoll HJ, Zeitz M, Selbmann HK, Deutsche Gesellschaft für Verdauungs-und Stoffwechselerkrankungen (2004) S3-guideline conference “Colorectal Cancer” 2004. Z Gastroenterol 42:1129–1177
Screening For Colorectal Cancer-United States, 1997 (1999) MMWR Morb Mortal Wkly Rep 48:116–121
Neale AV, Demers RY, Herman S (1989) Compliance with colorectal cancer screening in a high-risk occupational group. J Occup Med 31:1007–1012
Arveux P, Durand G, Milan C, Bedenne L, Levy D, Doan BD, Faivre J (1992) Views of a general population on mass screening for colorectal cancer: the burgundy study. Prev Med 21:574–581
Vernon SW, Acquavella JF, Yarborough CM, Hughes JI, Thar WE (1990) Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers. J Occup Med 32:46–51
Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, Zappa M, Atkin WS (2002) Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”—SCORE. J Natl Cancer Inst 94:1763–1772
UK Flexible Sigmoidoscopy Screening Trial Investigators (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359:1291–1300
Stephenson BM, Murday VA, Finan PJ, Quirke P, Dixon MF, Bishop DT (1993) Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut 34:96–100
Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T (1995) Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev Med 24:166–170
Schroy PC III, Wilson S, Afdhal N (1996) Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system. Am J Gastroenterol 91:1331–1337
Laville EA, Vernon SW, Jackson GL, Hughes JI (1989) Comparison of participants and nonparticipants in a work site cancer awareness and screening program. J Occup Med 31:221–232
Vernon SW, Acquavella JF, Douglass TS, Hughes JI (1989) Factors associated with participation in an occupational program for colorectal cancer screening. J Occup Med 31:458–463
Krevsky B, Niewiarowski T, League R, Herman H, Matz L, Fisher RS (1992) Flexible sigmoidoscopy screening in an industrial setting. Am J Gastroenterol 87:1759–1762
Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, Skovlund E, Tveit KM, Vatn MH, Hoff G (2002) Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol 37:568–573
Manus B, Bragelmann R, Armbrecht U, Stolte M, Stockbrugger RW (1996) Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre. Eur J Cancer Prev 5:49–55
Kremers SP, Mesters I, Pladdet IE, van den BB, Stockbrugger RW (2000) Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study. Cancer Epidemiol Biomarkers Prev 9:1127–1130
Schoen RE, Weissfeld JL, Bowen NJ, Switzer G, Baum A (2000) Patient satisfaction with screening flexible sigmoidoscopy. Arch Intern Med 160:1790–1796
Menees SB, Inadomi JM, Korsnes S, Elta GH (2005) Women patients’ preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc 62:219–223
Brown ML, Potosky AL, Thompson GB, Kessler LG (1990) The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey. Prev Med 19:562–574
Lewis SF, Jensen NM (1996) Screening sigmoidoscopy. Factors associated with utilization. J Gen Intern Med 11:542–544
Gohagan JK, Prorok PC, Hayes RB, Kramer BS (2000) The prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 21:251S–272S
Schroy PC III, Heeren T, Bliss CM, Bliss CM Jr, Pincus J, Wilson S, Prout M (2002) On-site screening sigmoidoscopy promotes long-term utilization but fails as a venue for training primary care endoscopists. Gastroenterology 122:1226–1234
Zubarik R, Eisen G, Zubarik J, Teal C, Benjamin S, Glaser M, Jack M (2000) Education improves colorectal cancer screening by flexible sigmoidoscopy in an inner city population. Am J Gastroenterol 95:509–512
Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M (2005) Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 97:347–357
Cappelli M, Hunter AG, Stern H, Humphreys L, Van Houten L, O’Rourke K, Viertelhausen S, Perras H, Lagarde AE (2002) Participation rates of Ashkenazi Jews in a colon cancer community-based screening/prevention study. Clin Genet 61:104–114
Andreoni B, Crosta C, Lotti M, Carloni M, Marzona L, Biffi R, Luca F, Pozzi S, Cenciarelli S, Senore C (2000) Flexible sigmoidoscopy as a colorectal cancer screening test in the general population: recruitment phase results of a randomized controlled trial in Lombardia, Italy. Chir Ital 52:257–262
Collett JA, Olynyk JK, Platell CF (2000) Flexible sigmoidoscopy screening for colorectal cancer in average-risk people: update of a community-based project. Med J Aust 173:463–466
Olynyk JK, Aquilia S, Fletcher DR, Dickinson JA (1996) Flexible sigmoidoscopy screening for colorectal cancer in average-risk subjects: a community-based pilot project. Med J Aust 165:74–76
Acknowledgements
S. Gölder and W. Vogt contributed equally to the publication and therefore share first authorship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gölder, S., Vogt, W., Lichti, H. et al. Acceptance of flexible sigmoidoscopy as a screening examination for colorectal cancer in an outpatient clinic. Int J Colorectal Dis 22, 387–394 (2007). https://doi.org/10.1007/s00384-006-0167-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-006-0167-9